CRO

Pfizer partners with Canada's drug research department; White House wants more research transparency;

 @DamianFierce: Despite the uptick in scrutiny, Indian clinical trial deaths were about the same in 2012 as in 2011. Story | Follow @DamianFierce

> As it continues to slash R&D spending around the world, Pfizer ($PFE) is partnering with the venture arm of Canada's Centre for Drug Research and Development, looking to speed the commercialization of new therapies. News

> The White House has issued a directive that will make more government-funded research publicly available. Story

> West Pharmaceutical is looking to shift its focus from contract manufacturing to proprietary products. Article

> Indian CRO GVK Biosciences is expanding in Taiwan, inking a distribution deal with that country's Genesis Genetics Asia. Release

> Clinical data contractor Medidata Solutions ($MDSO) has re-signed Purdue Pharma to a multi-year deal for its cloud-based clinical trial software. More

> According to a report from Industry Standard Research, the market for late-phase outsourced research is on the rise and will only continue its growth. Report